Sigmoid Pharma Limited

Dr. Ivan Coulter

Sigmoid logoDr. Ivan Coulter

Within the TRANS-INT project, Sigmoid aims to provide SmPill based formulations to ensure optimal targeted release of stable nanocarriers within the gastrointestinal tract. Sigmoid will ensure that the final formulation is manufactured under GMP conditions and is suitable for industrial/clinical applications.

 [go to website]

 

 

 

Map-Europe-UCD UCC Roche SARD Serocience IOV UU MHH UA SIGMOID VN UCL UCL UCD USC IRB CEA